These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3504872)

  • 21. Novel monobactams utilizing a siderophore uptake mechanism for the treatment of gram-negative infections.
    Mitton-Fry MJ; Arcari JT; Brown MF; Casavant JM; Finegan SM; Flanagan ME; Gao H; George DM; Gerstenberger BS; Han S; Hardink JR; Harris TM; Hoang T; Huband MD; Irvine R; Lall MS; Megan Lemmon M; Li C; Lin J; McCurdy SP; Mueller JP; Mullins L; Niosi M; Noe MC; Pattavina D; Penzien J; Plummer MS; Risley H; Schuff BP; Shanmugasundaram V; Starr JT; Sun J; Winton J; Young JA
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5989-94. PubMed ID: 22892121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Carumonam: antibacterial activity in vitro].
    Garlaschi ML; Lombardi A; Castiglioni G; Abbiati R; Varotto F
    G Ital Chemioter; 1991; 38(1-3):185-7. PubMed ID: 1365586
    [No Abstract]   [Full Text] [Related]  

  • 23. Susceptibility of 89,517 gram-negative isolates to aztreonam and other antibiotics.
    Lindsay G; Woods P
    Chemioterapia; 1987 Jun; 6(2 Suppl):106. PubMed ID: 3509363
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulation of the intestinal flora of mice by treatment with aztreonam and tigemonam.
    van Ogtrop ML; Guiot HF; Mattie H; van Strijen E; Sekh BR; van Furth R
    Antimicrob Agents Chemother; 1991 May; 35(5):983-5. PubMed ID: 1854181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
    Landinez R; Garcia M; Merino C
    Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
    [No Abstract]   [Full Text] [Related]  

  • 26. Aztreonam: preclinical studies.
    Bonner DP; Tanaka SK; Schwind RA
    N J Med; 1986 Jan; Spec No():20-5. PubMed ID: 3456495
    [No Abstract]   [Full Text] [Related]  

  • 27. [In vitro chemo-antibiotic sensitivity of gram-negative bacteria from various biological materials. Comparison between aztreonam and other agents].
    Monaci E; Monaci R; Giacalone G; Meoni S
    Minerva Med; 1987 May; 78(9):617-22. PubMed ID: 3587729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aztreonam in the therapy of severe gram-negative infections.
    Davies A; Stone J; Hassan A; Quarty P; Green T
    Chemioterapia; 1987 Jun; 6(2 Suppl):389-90. PubMed ID: 3509455
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and antibacterial activity of C-4 substituted monobactams.
    Mewshaw RE; Commons TJ
    J Antibiot (Tokyo); 1987 Nov; 40(11):1563-71. PubMed ID: 3121566
    [No Abstract]   [Full Text] [Related]  

  • 30. The newer cephalosporins. Aztreonam and imipenem.
    Ennis DM; Cobbs CG
    Infect Dis Clin North Am; 1995 Sep; 9(3):687-713. PubMed ID: 7490439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial agents and neuromuscular blockade.
    Mironidou M; Giala M; Papaioannidou P; Karakiulakis G; Zachariades B; Paradelis AG
    J Chemother; 1989 Jul; 1(4 Suppl):602-3. PubMed ID: 16312551
    [No Abstract]   [Full Text] [Related]  

  • 32. [BAL30072--an iron complexing beta lactam antibiotic against multidrug-resistant gram negative bacteria].
    Schmitz J
    Pharm Unserer Zeit; 2011 Mar; 40(2):98-9. PubMed ID: 21630531
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of aztreonam in the treatment of nosocomial pneumonia in the critically ill surgical patient.
    Boucher BA
    Am J Surg; 2000 Feb; 179(2A Suppl):45S-50S. PubMed ID: 10802265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relations of 4-fluoromethyl monobactams.
    Matsuda K; Nakagawa S; Nakano F; Inoue M; Mitsuhashi S
    J Antimicrob Chemother; 1987 Jun; 19(6):753-60. PubMed ID: 3497148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of aztreonam--a new monocyclic beta-lactam antibiotic.
    Friis H
    Dan Med Bull; 1985 Jun; 32(3):196-8. PubMed ID: 4040456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of aztreonam against other antibiotics used in urinary tract infections.
    Khan MT; Shah SH
    J Ayub Med Coll Abbottabad; 2001; 13(4):22-4. PubMed ID: 11873424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced bactericidal action of mouse macrophages by subinhibitory concentrations of monobactams.
    Iida-Tanaka K; Tanaka T; Irino S; Nagayama A
    J Antimicrob Chemother; 1986 Aug; 18(2):239-50. PubMed ID: 3759735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp].
    Vay CA; Almuzara MN; Rodríguez CH; Pugliese ML; Lorenzo Barba F; Mattera JC; Famiglietti AM
    Rev Argent Microbiol; 2005; 37(1):34-45. PubMed ID: 15991478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual antibacterial mechanisms of nisin Z against Gram-positive and Gram-negative bacteria.
    Kuwano K; Tanaka N; Shimizu T; Nagatoshi K; Nou S; Sonomoto K
    Int J Antimicrob Agents; 2005 Nov; 26(5):396-402. PubMed ID: 16226432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of aztreonam on natural immunity in mice.
    Ortega E; de Pablo MA; Gallego AM; Alvarez C; Pancorbo PL; Ruiz-Bravo A; de Cienfuegos GA
    Int J Antimicrob Agents; 1999 Sep; 13(1):41-6. PubMed ID: 10563409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.